+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Live Cell Encapsulation Market Size, Share & Trends Analysis Report By Polymer Type (Natural, Synthetic), By Application (Drug Delivery, Cell Transplantation), By Method, By Region, And Segment Forecasts, 2023 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • February 2023
  • Region: Global
  • Grand View Research
  • ID: 5748293
The global live cell encapsulation market size is projected to reach USD 286.5 million by 2030, registering a CAGR of 3.97% during the forecast period. Increasing adoption of live cell encapsulation in regenerative medicine, rising public-private investments in cell & gene therapies, and the growing significance of live cell encapsulation for therapeutic purposes are key factors driving the industry. Furthermore, major advantages associated with live cell encapsulation of a drug or treatment system include easy administration, the possibility to control the accurate release rate of a drug over time, and the provision of desired, pre-programmed drug release anticipated to boost the industry growth over the study period. Increasing public-private funding & investments in cell and gene therapies are projected to drive the market during the forecast period.

For instance, in June 2022, Immuneel Therapeutics raised series A funding of USD 15 million to develop affordable cell and gene therapy for cancer patients in India. In October 2022, Vita Therapeutics received series B funding of USD 31 million for the development of cell therapies for neuromuscular diseases and cancers. Hence, increasing funding may boost R&D activities, ultimately increasing the demand for live cell encapsulation techniques. The COVID-19 infection affected multiple organs leading to an increase in research studies on chronic or acute organ damage caused by the virus. Tissue engineering strategies including live cell encapsulation techniques are used to treat the damages. For instance, the live cell encapsulation technique with alginate was used to deliver hormones to the body for female reproductive system damages caused due to COVID-19 infection.

Thus, the COVID-19 pandemic had a positive impact on the industry. Moreover, live cell encapsulation technology has proven to be a suitable treatment strategy for diseases, such as heart failure, diabetes, cancer, anemia, or the central nervous system. For instance, encapsulated islet cells are stem cells enclosed in a protective capsule to treat type 1 diabetes. Encapsulated islet cells prevent low and high sugar levels from occurring, and eliminate the need for daily blood glucose tests & take insulin daily. Hence, the growing significance of live cell encapsulation for therapeutic purposes is expected to drive the adoption of these methods. Furthermore, increasing strategic initiatives, such as partnerships and clinical trials on cell encapsulation technology, by operating players are expected to drive the industry.

For instance, in February 2021, ViaCyte, Inc. announced the initiation of phase 2 clinical study of encapsulated cell therapy to treat type 1 diabetes. In addition, in November 2022, Nanoscribe and BIO INX expanded their partnership with the launch of novel biocompatible high-resolution bioink HYDROBIO INX for live cell encapsulation. On the other hand, the high product manufacturing costs may hamper the industry during the forecast years. Live cell encapsulation technology must fulfill strict requirements, such as biosafety, performance, biocompatibility, stability, purity, and retrievability, leading to high production costs. Such high costs may not be affordable for small- and medium-sized companies and hamper market growth to a certain extent. In addition, the limited availability of high-quality raw materials may hinder growth. However, industry players are continuously developing high-quality raw materials, reducing the production cost of the technology.

Live Cell Encapsulation Market Report Highlights

  • The natural polymers segment held the largest share in 2022 owing to its advantages, such as low toxicity, renewability, biocompatibility, flexibility to modification, and biodegradability
  • The microencapsulation method segment accounted for the largest share in 2022 due to the benefits offered by microencapsulation, including pre-programmed drug-release profiles, easy administration, and the ability of the technique to control the release rate of a fused drug over periods (hours to months)
  • The drug delivery application segment dominated the industry in 2022 owing to the potential application of drug delivery to treat various diseases, such as cancer, tuberculosis, diabetes, and rheumatoid arthritis, in the form of tablets, capsules, or parenteral dosage forms
  • North America held the largest revenue share in 2022. The large share can be attributed to established healthcare infrastructure, increased per capita healthcare expenditure, and rising funding & investments in cell and gene therapies space in the region

Table of Contents

Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation

Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends, & Scope
3.1 Parent Market Analysis
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Increasing Adoption Of Live Cell Encapsulation In Regenerative Medicine
3.2.1.2 Rising Public-Private Investments In Cell And Gene Therapies
3.2.1.3 Growing Significance Of Live Cell Encapsulation For Therapeutic Purposes
3.2.2 Market Restraint Analysis
3.2.2.1 High Product Manufacturing Costs
3.2.2.2 Limited Market Availability Of High-Quality Raw Materials
3.3 Penetration &Growth Prospect Mapping
3.4 Live Cell Encapsulation Market - Porter’s Analysis
3.5 Live Cell Encapsulation Market - Swot Analysis
3.6 Covid-19 Impact Analysis

Chapter 4 Polymer Type Business Analysis
4.1 Live Cell Encapsulation Market-Polymer Type Movement Analysis
4.2 Natural Polymers
4.2.1 Global Natural Polymers Market, 2018 - 2030 (USD Million)
4.2.2 Alginate
4.2.2.1 Global Alginate Market, 2018 - 2030 (USD Million)
4.2.3 Chitosan
4.2.3.1 Global Chitosan Market, 2018 - 2030 (USD Million)
4.2.4 Cellulose
4.2.4.1 Global Cellulose Market, 2018 - 2030 (USD Million)
4.2.5 Others
4.2.5.1 Global Others Market, 2018 - 2030 (USD Million)
4.3 Synthetic Polymers
4.3.1 Global Synthetic Polymers Market, 2018 - 2030 (USD Million)

Chapter 5 Method Business Analysis
5.1 Live Cell Encapsulation Market-Method Movement Analysis
5.2 Microencapsulation
5.2.1 Global Microencapsulation Market, 2018 - 2030 (USD Million)
5.3 Macroencapsulation
5.3.1 Global Macroencapsulation Market, 2018 - 2030 (USD Million)
5.4 Nanoencapsulation
5.4.1 Global Nanoencapsulation Market, 2018 - 2030 (USD Million)

Chapter 6 Application Business Analysis
6.1 Live Cell Encapsulation Market-Application Movement Analysis
6.2 Drug Delivery
6.2.1 Global Drug Delivery Market, 2018 - 2030 (USD Million)
6.3 Regenerative Medicine
6.3.1 Global Regenerative Medicine Market, 2018 - 2030 (USD Million)
6.4 Cell Transplantation
6.4.1 Global Cell Transplantation Market, 2018 - 2030 (USD Million)
6.5 Others
6.5.1 Global Others Market, 2018 - 2030 (USD Million)

Chapter 7 Regional Business Analysis
7.1 Live Cell Encapsulation Market: Regional Movement Analysis
7.2 North America
7.2.1 Swot Analysis
7.2.1.1 North America Live Cell Encapsulation Market, 2018 - 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 Key Country Dynamics
7.2.2.2 Competitive Scenario
7.2.2.3 U.S. Live Cell Encapsulation Market, 2018 - 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Key Country Dynamics
7.2.3.2 Competitive Scenario
7.2.3.3 Canada Live Cell Encapsulation Market, 2018 - 2030 (USD Million)
7.3 Europe
7.3.1 Swot Analysis
7.3.1.1 Europe Live Cell Encapsulation Market Estimates And Forecast, 2018-2030, (Usd Million)
7.3.2 U.K.
7.3.2.1 Key Country Dynamics
7.3.2.2 Competitive Scenario
7.3.2.3 U.K. Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.3.3 Germany
7.3.3.1 Key Country Dynamics
7.3.3.2 Competitive Scenario
7.3.3.3 Germany Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.3.4 France
7.3.4.1 Key Country Dynamics
7.3.4.2 Competitive Scenario
7.3.4.3 France Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.3.5 Italy
7.3.5.1 Key Country Dynamics
7.3.5.2 Competitive Scenario
7.3.5.3 Italy Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.3.6 Spain
7.3.6.1 Key Country Dynamics
7.3.6.2 Competitive Scenario
7.3.6.3 Spain Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.3.7 Denmark
7.3.7.1 Key Country Dynamics
7.3.7.2 Competitive Scenario
7.3.7.3 Denmark Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.3.8 Sweden
7.3.8.1 Key Country Dynamics
7.3.8.2 Competitive Scenario
7.3.8.3 Sweden Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.3.9 Norway
7.3.9.1 Key Country Dynamics
7.3.9.2 Competitive Scenario
7.3.9.3 Norway Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.4 Asia Pacific
7.4.1 Swot Analysis
7.4.1.1 Asia Pacific Vacuum Blood Collection Tube, 2018-2030, (Usd Million)
7.4.2 Japan
7.4.2.1 Key Country Dynamics
7.4.2.2 Competitive Scenario
7.4.2.3 Japan Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.4.3 China
7.4.3.1 Key Country Dynamics
7.4.3.2 Competitive Scenario
7.4.3.3 China Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.4.4 India
7.4.4.1 Key Country Dynamics
7.4.4.2 Competitive Scenario
7.4.4.3 India Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.4.5 Australia
7.4.5.1 Key Country Dynamics
7.4.5.2 Competitive Scenario
7.4.5.3 Australia Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.4.6 Thailand
7.4.6.1 Key Country Dynamics
7.4.6.2 Competitive Scenario
7.4.6.3 Thailand Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.4.7 South Korea
7.4.7.1 Key Country Dynamics
7.4.7.2 Competitive Scenario
7.4.7.3 South Korea Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.5 Latin America
7.5.1 Swot Analysis
7.5.1.1 Latin America Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.5.2 Brazil
7.5.2.1 Key Country Dynamics
7.5.2.2 Competitive Scenario
7.5.2.3 Brazil Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.5.3 Mexico
7.5.3.1 Key Country Dynamics
7.5.3.2 Competitive Scenario
7.5.3.3 Mexico Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.5.4 Argentina
7.5.4.1 Key Country Dynamics
7.5.4.2 Competitive Scenario
7.5.4.3 Argentina Live Cell Encapsulation Market, 2018-2030, (Usd Million)
7.6 Middle East & Africa (Mea)
7.6.1 Swot Analysis
7.6.1.1 Mea Live Cell Encapsulation Market Estimates And Forecast, 2018-2030, (Usd Million)
7.6.2 South Africa
7.6.2.1 Key Country Dynamics
7.6.2.2 Competitive Scenario
7.6.2.3 South Africa Live Cell Encapsulation Market Estimates And Forecast, 2018-2030, (Usd Million)
7.6.3 Saudi Arabia
7.6.3.1 Key Country Dynamics
7.6.3.2 Competitive Scenario
7.6.3.3 Saudi Arabia Live Cell Encapsulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.4 Uae
7.6.4.1 Key Country Dynamics
7.6.4.2 Competitive Scenario
7.6.4.3 Uae Live Cell Encapsulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
7.6.5 Kuwait
7.6.5.1 Key country dynamics
7.6.5.2 Competitive scenario
7.6.5.3 Kuwait live cell encapsulation market estimates and forecast, 2018-2030 (USD million)

Chapter 8 Competitive Landscape
8.1 Participant’s Overview
8.1.1 AUSTRIANOVA
8.1.2 MERCK KGAA
8.1.3 SPHERE FLUIDICS LIMITED
8.1.4 VIACYTE, INC.
8.1.5 BLACKTRACE HOLDINGS LTD (DOLOMITE MICROFLUIDICS)
8.1.6 BIO INX
8.1.7 LIVING CELL TECHNOLOGIES LIMITED
8.1.8 SIGILON THERAPEUTICS, INC.
8.1.9 ISOGEN
8.1.10 DIATRANZ OTSUKA LTD
8.2 Financial Performance
8.3 Participant Categorization
8.3.1 Market Leaders
8.3.1.1 Live Cell Encapsulation Market Share Analysis, 2022
8.3.2 Strategy Mapping
8.3.2.1 Expansion
8.3.2.2 Acquisition
8.3.2.3 Collaborations
8.3.2.4 Product/service launch
8.3.2.5 Partnerships
8.3.2.6 Others

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 4 Global live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 5 Global live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 6 Global live cell encapsulation market, by region, 2018 - 2030 (USD Million)
Table 7 North America live cell encapsulation market, by country, 2018 - 2030 (USD Million)
Table 8 North America live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 9 North America live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 10 North America live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 11 U.S. live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 12 U.S. live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 13 U.S. live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 14 Canada live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 15 Canada live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 16 Canada live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 17 Europe live cell encapsulation market, by country, 2018 - 2030 (USD Million)
Table 18 Europe live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 19 Europe live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 20 Europe live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 21 U.K. live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 22 U.K. live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 23 U.K. live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 24 Germany live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 25 Germany live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 26 Germany live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 27 France live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 28 France live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 29 France live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 30 Italy live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 31 Italy live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 32 Italy live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 33 Spain live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 34 Spain live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 35 Spain live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 36 Denmark live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 37 Denmark live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 38 Denmark live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 39 Sweden live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 40 Sweden live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 41 Sweden live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 42 Norway live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 43 Norway live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 44 Norway live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 45 Asia Pacific live cell encapsulation market, by country, 2018 - 2030 (USD Million)
Table 46 Asia Pacific live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 47 Asia Pacific live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 48 Asia Pacific live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 49 Japan live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 50 Japan live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 51 Japan live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 52 China live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 53 China live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 54 China live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 55 India live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 56 India live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 57 India live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 58 Australia live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 59 Australia live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 60 Australia live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 61 Thailand live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 62 Thailand live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 63 Thailand live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 64 South Korea live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 65 South Korea live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 66 South Korea live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 67 Latin America live cell encapsulation market, by country, 2018 - 2030 (USD Million)
Table 68 Latin America live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 69 Latin America live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 70 Latin America live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 71 Brazil live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 72 Brazil live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 73 Brazil live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 74 Mexico live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 75 Mexico live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 76 Mexico live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 77 Argentina live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 78 Argentina live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 79 Argentina live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 80 Middle East & Africa live cell encapsulation market, by country, 2018 - 2030 (USD Million)
Table 81 Middle East & Africa live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 82 Middle East & Africa live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 83 Middle East & Africa live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 84 South Africa live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 85 South Africa live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 86 South Africa live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 88 Saudi Arabia live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 89 Saudi Arabia live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 90 UAE live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 91 UAE live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 92 UAE live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 93 Kuwait live cell encapsulation market, by polymer type, 2018 - 2030 (USD Million)
Table 94 Kuwait live cell encapsulation market, by method, 2018 - 2030 (USD Million)
Table 95 Kuwait live cell encapsulation market, by application, 2018 - 2030 (USD Million)
Table 96 Participant’s overview
Table 97 Financial performance
Table 98 Key companies undergoing expansions
Table 99 Key companies undergoing acquisitions
Table 100 Key companies undergoing collaborations
Table 101 Key companies launching new products/services
Table 102 Key companies undergoing partnerships
Table 103 Key companies undertaking other strategies

List of Figures
Fig. 1 Market research process
Fig. 2 Data triangulation techniques
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Market summary, 2022 (USD Million)
Fig. 9 Market segmentation & scope
Fig. 10 Market driver impact
Fig. 11 Market restraint impact
Fig. 12 Penetration & growth prospect mapping
Fig. 13 Porter’s analysis
Fig. 14 SWOT analysis
Fig. 15 Live cell encapsulation market: Polymer type outlook and key takeaways
Fig. 16 Live cell encapsulation market: Polymer type movement analysis
Fig. 17 Global natural polymers market, 2018 - 2030 (USD Million)
Fig. 18 Global alginate market, 2018 - 2030 (USD Million)
Fig. 19 Global chitosan market, 2018 - 2030 (USD Million)
Fig. 20 Global cellulose market, 2018 - 2030 (USD Million)
Fig. 21 Global others market, 2018 - 2030 (USD Million)
Fig. 22 Global synthetic polymers market, 2018 - 2030 (USD Million)
Fig. 23 Live cell encapsulation market: Method outlook and key takeaways
Fig. 24 Live cell encapsulation market: Method movement analysis
Fig. 25 Global microencapsulation market, 2018 - 2030 (USD Million)
Fig. 26 Global macroencapsulation market, 2018 - 2030 (USD Million)
Fig. 27 Global nanoencapsulation market, 2018 - 2030 (USD Million)
Fig. 28 Live cell encapsulation market: Application outlook and key takeaways
Fig. 29 Live cell encapsulation market: Application movement analysis
Fig. 30 Global drug delivery market, 2018 - 2030 (USD Million)
Fig. 31 Global regenerative medicine market, 2018 - 2030 (USD Million)
Fig. 32 Global cell transplantation market, 2018 - 2030 (USD Million)
Fig. 33 Global others market, 2018 - 2030 (USD Million)
Fig. 34 Live cell encapsulation market: Regional outlook and key takeaways
Fig. 35 North America: SWOT Analysis
Fig. 36 North America live cell encapsulation market, 2018 - 2030 (USD Million)
Fig. 37 U.S. key country dynamics
Fig. 38 U.S. live cell encapsulation market, 2018 - 2030 (USD Million)
Fig. 39 Canada key country dynamics
Fig. 40 Canada live cell encapsulation market, 2018 - 2030 (USD Million)
Fig. 41 Europe: SWOT Analysis
Fig. 42 Europe live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 U.K. key country dynamics
Fig. 44 U.K. live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Germany key country dynamics
Fig. 46 Germany live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 France key country dynamics
Fig. 48 France live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 49 Italy key country dynamics
Fig. 50 Italy live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Spain key country dynamics
Fig. 52 Spain live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Denmark key country dynamics
Fig. 54 Denmark live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 55 Sweden key country dynamics
Fig. 56 Sweden live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 57 Norway key country dynamics
Fig. 58 Norway live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 59 Asia-Pacific: SWOT Analysis
Fig. 60 Asia-Pacific live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 61 Japan key country dynamics
Fig. 62 Japan live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 63 China key country dynamics
Fig. 64 China live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 65 India key country dynamics
Fig. 66 India live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 67 Australia key country dynamics
Fig. 68 Australia live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 69 Thailand key country dynamics
Fig. 70 Thailand live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 71 South Korea key country dynamics
Fig. 72 South Korea live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 73 Latin America: SWOT Analysis
Fig. 74 Latin America live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 75 Brazil key country dynamics
Fig. 76 Brazil live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 77 Mexico key country dynamics
Fig. 78 Mexico live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 79 Argentina key country dynamics
Fig. 80 Argentina live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 81 MEA: SWOT Analysis
Fig. 82 MEA live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 83 South Africa key country dynamics
Fig. 84 South Africa live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 85 Saudi Arabia key country dynamics
Fig. 86 Saudi Arabia live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 87 UAE key country dynamics
Fig. 88 UAE live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 89 Kuwait key country dynamics
Fig. 90 Kuwait live cell encapsulation market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 91 Market participant categorization
Fig. 92 Live cell encapsulation market share analysis, 2022
Fig. 93 Strategy framework

Companies Mentioned

  • AUSTRIANOVA
  • MERCK KGAA
  • SPHERE FLUIDICS LIMITED
  • VIACYTE, INC.
  • BLACKTRACE HOLDINGS LTD (DOLOMITE MICROFLUIDICS)
  • BIO INX
  • LIVING CELL TECHNOLOGIES LIMITED
  • SIGILON THERAPEUTICS, INC.
  • ISOGEN
  • DIATRANZ OTSUKA LTD

Methodology

Loading
LOADING...

Table Information